In addition to liver tumor incidence, we examined immune cell infiltration, fibrosis and cell proliferation in mouse livers upon ablation of Sphk2. We also assessed the anti-cancer effects of SphK2 deficiency on cell viability, clonogenicity and cell cycle in hepatic cells exposed to a high-fat environment. Here, SPHK2 is linked to cancer.